These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 30975755)
1. Structural basis for ligand modulation of the CCR2 conformational landscape. Taylor BC; Lee CT; Amaro RE Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8131-8136. PubMed ID: 30975755 [TBL] [Abstract][Full Text] [Related]
2. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists. Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736 [TBL] [Abstract][Full Text] [Related]
3. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations. An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162 [TBL] [Abstract][Full Text] [Related]
4. Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2. Zweemer AJ; Bunnik J; Veenhuizen M; Miraglia F; Lenselink EB; Vilums M; de Vries H; Gibert A; Thiele S; Rosenkilde MM; IJzerman AP; Heitman LH Mol Pharmacol; 2014 Oct; 86(4):358-68. PubMed ID: 25024169 [TBL] [Abstract][Full Text] [Related]
5. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor. Singh R; Sobhia ME J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007 [TBL] [Abstract][Full Text] [Related]
6. Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2. Toy L; Huber ME; Schmidt MF; Weikert D; Schiedel M ACS Chem Biol; 2022 Aug; 17(8):2142-2152. PubMed ID: 35838163 [TBL] [Abstract][Full Text] [Related]
7. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents. David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817 [TBL] [Abstract][Full Text] [Related]
8. Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study. Kothandan G; Gadhe CG; Cho SJ PLoS One; 2012; 7(3):e32864. PubMed ID: 22479344 [TBL] [Abstract][Full Text] [Related]
9. Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. Apel AK; Cheng RKY; Tautermann CS; Brauchle M; Huang CY; Pautsch A; Hennig M; Nar H; Schnapp G Structure; 2019 Mar; 27(3):427-438.e5. PubMed ID: 30581043 [TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7. Jaeger K; Bruenle S; Weinert T; Guba W; Muehle J; Miyazaki T; Weber M; Furrer A; Haenggi N; Tetaz T; Huang CY; Mattle D; Vonach JM; Gast A; Kuglstatter A; Rudolph MG; Nogly P; Benz J; Dawson RJP; Standfuss J Cell; 2019 Aug; 178(5):1222-1230.e10. PubMed ID: 31442409 [TBL] [Abstract][Full Text] [Related]
11. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2. Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641 [TBL] [Abstract][Full Text] [Related]
12. Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles. De Paula VS; Gomes NS; Lima LG; Miyamoto CA; Monteiro RQ; Almeida FC; Valente AP J Mol Biol; 2013 Nov; 425(22):4479-95. PubMed ID: 23938203 [TBL] [Abstract][Full Text] [Related]
13. Ligand supported homology modeling and docking evaluation of CCR2: docked pose selection by consensus scoring. Kim JH; Lim JW; Lee SW; Kim K; No KT J Mol Model; 2011 Oct; 17(10):2707-16. PubMed ID: 21213000 [TBL] [Abstract][Full Text] [Related]
14. Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies. Amin SA; Adhikari N; Baidya SK; Gayen S; Jha T J Biomol Struct Dyn; 2019 Jan; 37(1):75-94. PubMed ID: 29251559 [TBL] [Abstract][Full Text] [Related]
15. Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism. den Hollander LS; Béquignon OJM; Wang X; van Wezel K; Broekhuis J; Gorostiola González M; de Visser KE; IJzerman AP; van Westen GJP; Heitman LH Biochem Pharmacol; 2023 Feb; 208():115399. PubMed ID: 36581051 [TBL] [Abstract][Full Text] [Related]
16. Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach. Thiele S; Steen A; Jensen PC; Mokrosinski J; Frimurer TM; Rosenkilde MM J Biol Chem; 2011 Oct; 286(43):37543-54. PubMed ID: 21878623 [TBL] [Abstract][Full Text] [Related]